News & Updates

The KV7 potassium channel opener azetukalner helps improve symptoms of major depressive disorder (MDD) in adults, according to the results of the proof-of-concept, phase II X-NOVA study.

Intracavernosal injection (ICI) of aviptadil with phentolamine mesylate (AvP) demonstrates efficacy in more than half of the men with refractory erectile dysfunction (ED) who participated in a recent study.

Dependence on or excessive use of cannabis appears to increase the risk of erectile dysfunction (ED), testosterone deficiency (TD), and phosphodiesterase-5 inhibitor (PDE5-i) prescription, reveals a study.

In the treatment of patients with resistant hypertension, amiloride is no better or worse than spironolactone at reducing home systolic blood pressure (SBP) levels, according to a study.

For older adults who received treatment with antipsychotics to manage delirium, medication discontinuation leads to better outcomes, including reduced risks of all-cause rehospitalization and mortality, compared with continued use, according to a study.

Approximately one in six atrial fibrillation (AF) patients who sustained a stroke experiences another one within 5 years despite receiving modern preventive therapy, according to a systematic review and meta-analysis.

The addition of elebsiran, an investigational small interfering ribonucleic acid (siRNA), to pegylated interferon (PEG-IFN) alfa led to a higher rate of hepatitis B surface antigen (HBsAg) loss in patients with chronic HB virus (HBV) infection compared with PEG-IFN alfa alone, according to the ENSURE study presented at EASL 2025.